|
Market Closed -
Euronext Paris
20:55:00 30/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 157.60 EUR | +1.16% |
|
+3.55% | +32.44% |
| 10-22 | Ipsen: Better-than-expected Q3 overshadowed by 2027 Somatuline erosion and arbitration risk |  |
| 10-22 | Ipsen S.A. Upgrades Financial Guidance for the Full-Year 2026 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPSEN | Other Pharmaceuticals | +1.16% | +3.55% | +32.44% | +29.18% | +76.29% | 14.26B |  |  | |
- Stock Market
- Stocks
- IPN Stock
- Charts Ipsen
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
